Feature-Based Machine Learning Model for Real-Time Hypoglycemia Prediction.


Journal

Journal of diabetes science and technology
ISSN: 1932-2968
Titre abrégé: J Diabetes Sci Technol
Pays: United States
ID NLM: 101306166

Informations de publication

Date de publication:
07 2021
Historique:
pubmed: 2 6 2020
medline: 29 10 2021
entrez: 2 6 2020
Statut: ppublish

Résumé

Hypoglycemia is a serious health concern in youth with type 1 diabetes (T1D). Real-time data from continuous glucose monitoring (CGM) can be used to predict hypoglycemic risk, allowing patients to take timely intervention measures. A machine learning model is developed for probabilistic prediction of hypoglycemia (<70 mg/dL) in 30- and 60-minute time horizons based on CGM datasets obtained from 112 patients over a range of 90 days consisting of over 1.6 million CGM values under normal living conditions. A comprehensive set of features relevant for hypoglycemia are developed and a parsimonious subset with most influence on predicting hypoglycemic risk is identified. Model performance is evaluated both with and without contextual information on insulin and carbohydrate intake. The model predicted hypoglycemia with >91% sensitivity for 30- and 60-minute prediction horizons while maintaining specificity >90%. Inclusion of insulin and carbohydrate data yielded performance improvement for 60-minute but not for 30-minute predictions. Model performance was highest for nocturnal hypoglycemia (~95% sensitivity). Shortterm (less than one hour) and medium-term (one to four hours) features for good prediction performance are identified. Innovative feature identification facilitated high performance for hypoglycemia risk prediction in pediatric youth with T1D. Timely alerts of impending hypoglycemia may enable proactive measures to avoid severe hypoglycemia and achieve optimal glycemic control. The model will be deployed on a patient-facing smartphone application in an upcoming pilot study.

Sections du résumé

BACKGROUND
Hypoglycemia is a serious health concern in youth with type 1 diabetes (T1D). Real-time data from continuous glucose monitoring (CGM) can be used to predict hypoglycemic risk, allowing patients to take timely intervention measures.
METHODS
A machine learning model is developed for probabilistic prediction of hypoglycemia (<70 mg/dL) in 30- and 60-minute time horizons based on CGM datasets obtained from 112 patients over a range of 90 days consisting of over 1.6 million CGM values under normal living conditions. A comprehensive set of features relevant for hypoglycemia are developed and a parsimonious subset with most influence on predicting hypoglycemic risk is identified. Model performance is evaluated both with and without contextual information on insulin and carbohydrate intake.
RESULTS
The model predicted hypoglycemia with >91% sensitivity for 30- and 60-minute prediction horizons while maintaining specificity >90%. Inclusion of insulin and carbohydrate data yielded performance improvement for 60-minute but not for 30-minute predictions. Model performance was highest for nocturnal hypoglycemia (~95% sensitivity). Shortterm (less than one hour) and medium-term (one to four hours) features for good prediction performance are identified.
CONCLUSIONS
Innovative feature identification facilitated high performance for hypoglycemia risk prediction in pediatric youth with T1D. Timely alerts of impending hypoglycemia may enable proactive measures to avoid severe hypoglycemia and achieve optimal glycemic control. The model will be deployed on a patient-facing smartphone application in an upcoming pilot study.

Identifiants

pubmed: 32476492
doi: 10.1177/1932296820922622
pmc: PMC8258517
doi:

Substances chimiques

Blood Glucose 0
Hypoglycemic Agents 0
Insulin 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

842-855

Subventions

Organisme : FDA HHS
ID : P50 FD006428
Pays : United States

Commentaires et corrections

Type : ErratumIn
Type : ErratumIn

Références

Diabetes Technol Ther. 2017 Jun;19(S3):S25-S37
pubmed: 28585879
Diabetes Technol Ther. 2014 Oct;16(10):667-78
pubmed: 24918271
IEEE J Biomed Health Inform. 2019 May;23(3):1251-1260
pubmed: 29993728
Pediatr Diabetes. 2018 Feb;19(1):114-120
pubmed: 28429581
IEEE Trans Cybern. 2016 Jul;46(7):1704-14
pubmed: 27244754
J Diabetes Sci Technol. 2010 Mar 01;4(2):404-18
pubmed: 20307402
Diabetes Technol Ther. 2013 Oct;15(10):792-801
pubmed: 23883406
Diabetes Care. 2018 Oct;41(10):2155-2161
pubmed: 30089663
PLoS One. 2017 Nov 7;12(11):e0187754
pubmed: 29112978
Diabetes Care. 1987 Sep-Oct;10(5):617-21
pubmed: 3677982
IEEE Trans Biomed Eng. 2007 May;54(5):931-7
pubmed: 17518291
J Diabetes Sci Technol. 2020 Mar;14(2):250-256
pubmed: 31390891
J Diabetes Sci Technol. 2014 Jan 1;8(1):117-122
pubmed: 24876547
IEEE Trans Biomed Eng. 2012 Jun;59(6):1550-60
pubmed: 22374344
Diabetes Technol Ther. 2018 Jun;20(S2):S250-S253
pubmed: 29873525
N Engl J Med. 2019 Oct 31;381(18):1707-1717
pubmed: 31618560
J Diabetes Sci Technol. 2008 Jul;2(4):612-21
pubmed: 19885237
Diabetes Technol Ther. 2018 Jun;20(6):395-402
pubmed: 29901421
Diabetes Technol Ther. 2008 Dec;10(6):441-4
pubmed: 19049372
Diabet Med. 2010 Jan;27(1):72-8
pubmed: 20121892
Diabetes Technol Ther. 2013 Jul;15(7):538-43
pubmed: 23631608
IEEE J Biomed Health Inform. 2019 Mar;23(2):650-659
pubmed: 29993992
J Diabetes Sci Technol. 2016 Aug 22;10(5):1149-60
pubmed: 27381030
J Diabetes Sci Technol. 2019 Sep;13(5):919-927
pubmed: 30650997
Int J Numer Method Biomed Eng. 2017 Jun;33(6):
pubmed: 27644067
Diabetes Technol Ther. 2009 Apr;11(4):243-53
pubmed: 19344199
Diabetes Care. 2010 Jun;33(6):1249-54
pubmed: 20508231
J Diabetes Sci Technol. 2017 Jan;11(1):138-147
pubmed: 27530720
J Diabetes Sci Technol. 2008 Jan;2(1):158-63
pubmed: 19578532
J Pediatr Endocrinol Metab. 1998 Mar;11 Suppl 1:189-94
pubmed: 9642659
IEEE J Biomed Health Inform. 2020 Jul;24(7):2064-2072
pubmed: 31796419
IEEE J Biomed Health Inform. 2020 Feb;24(2):414-423
pubmed: 31369390
J Diabetes Sci Technol. 2018 Jan;12(1):190-198
pubmed: 28741369
BMC Med Inform Decis Mak. 2019 Nov 14;19(1):223
pubmed: 31727058
Physiol Meas. 2004 Aug;25(4):905-20
pubmed: 15382830
J Diabetes Sci Technol. 2010 Jan 01;4(1):25-33
pubmed: 20167164
J Diabetes Sci Technol. 2015 Apr 30;9(5):1126-37
pubmed: 25931581
Health Informatics J. 2019 Dec;25(4):1170-1187
pubmed: 29278956
PLoS One. 2019 Dec 11;14(12):e0219636
pubmed: 31826018
IEEE J Biomed Health Inform. 2013 Jan;17(1):71-81
pubmed: 23008265
J Diabetes Sci Technol. 2014 Jul;8(4):731-7
pubmed: 24876412
Diabetes Technol Ther. 2013 Aug;15(8):634-43
pubmed: 23848178
Pediatr Diabetes. 2017 Aug;18(5):332-339
pubmed: 27125223
Int J Behav Med. 2014;21(5):804-10
pubmed: 24190791
Ind Eng Chem Res. 2013 Sep 4;52(35):
pubmed: 24187436
IEEE Trans Inf Technol Biomed. 2010 Jan;14(1):157-65
pubmed: 19858035
J Diabetes Sci Technol. 2010 Sep 01;4(5):1146-55
pubmed: 20920434
J Diabetes Sci Technol. 2007 Sep;1(5):624-9
pubmed: 19885130
J Diabetes Sci Technol. 2020 Nov;14(6):1081-1087
pubmed: 31441336
Diabetes Technol Ther. 2010 Jan;12(1):81-8
pubmed: 20082589
J Diabetes Sci Technol. 2012 Sep 01;6(5):1142-7
pubmed: 23063041
Diabetes. 1999 Mar;48(3):445-51
pubmed: 10078542
J Diabetes Sci Technol. 2018 Mar;12(2):282-294
pubmed: 29493359
J Clin Psychol Med Settings. 2008 Sep;15(3):252-9
pubmed: 19104970
Comput Methods Programs Biomed. 2014;113(1):144-52
pubmed: 24192453
IEEE J Biomed Health Inform. 2019 Apr 17;:
pubmed: 30998484
Diabetes Technol Ther. 2005 Feb;7(1):3-14
pubmed: 15738700
Diabetes Care. 2015 Mar;38(3):355-64
pubmed: 25205142
J Diabetes Sci Technol. 2018 Mar;12(2):265-272
pubmed: 29493356

Auteurs

Darpit Dave (D)

Department of Industrial and Systems Engineering, Texas A&M University, College Station, TX, USA.

Daniel J DeSalvo (DJ)

Baylor College of Medicine, Houston, TX, USA.
Texas Children's Hospital, Houston, TX, USA.

Balakrishna Haridas (B)

Department of Biomedical Engineering, Texas A&M University, College Station, TX, USA.

Siripoom McKay (S)

Baylor College of Medicine, Houston, TX, USA.
Texas Children's Hospital, Houston, TX, USA.

Akhil Shenoy (A)

Baylor College of Medicine, Houston, TX, USA.

Chester J Koh (CJ)

Baylor College of Medicine, Houston, TX, USA.
Texas Children's Hospital, Houston, TX, USA.

Mark Lawley (M)

Department of Industrial and Systems Engineering, Texas A&M University, College Station, TX, USA.

Madhav Erraguntla (M)

Department of Industrial and Systems Engineering, Texas A&M University, College Station, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH